Choroidal thickness changes after intravitreal ranibizumab and photodynamic therapy in recurrent polypoidal choroidal vasculopathy

American Journal of Ophthalmology

Volumn 156, Issue 3, 2013, Pages 548-556

  Maruko, Ichiro ^a   Iida, Tomohiro ^a,b   Oyamada, Hiroshi ^a   Sugano, Yukinori ^a   Ojima, Akira ^a   Sekiryu, Tetsuju ^a  

^a FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

^b TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

RANIBIZUMAB;

ADULT; AGED; ARTICLE; CASE STUDY; CLINICAL ARTICLE; CONTACT LENS; CONTROLLED STUDY; CORNEA THICKNESS; DIGITAL IMAGING; DISEASE ACTIVITY; FEMALE; FLUORESCENCE ANGIOGRAPHY; FOLLOW UP; HUMAN; INDIRECT OPHTHALMOSCOPE; MALE; OBSERVATIONAL STUDY; OPTICAL COHERENCE TOMOGRAPHY; PHOTODYNAMIC THERAPY; POLYPOIDAL CHOROIDAL VASCULOPATHY; PRIORITY JOURNAL; RECURRENT DISEASE; RETREATMENT; RETROSPECTIVE STUDY; SLIT LAMP; SUBFOVEAL CHOROIDAL THICKNESS; VISUAL ACUITY;

AGED; AGED, 80 AND OVER; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL, HUMANIZED; CHOROID; CHOROID DISEASES; COLORING AGENTS; COMBINED MODALITY THERAPY; FEMALE; FLUORESCEIN ANGIOGRAPHY; FOLLOW-UP STUDIES; HUMANS; INDOCYANINE GREEN; MALE; MIDDLE AGED; OPHTHALMOSCOPY; ORGAN SIZE; PHOTOCHEMOTHERAPY; POLYPS; RECURRENCE; RETROSPECTIVE STUDIES; TOMOGRAPHY, OPTICAL COHERENCE;

EID: 84882244507     PISSN: 00029394     EISSN: 18791891     Source Type: Journal    
DOI: 10.1016/j.ajo.2013.03.041     Document Type: Article

References (35)

1. L.A. Yannuzzi, J. Sorenson, R.F. Spaide, and B. Lipson Idiopathic polypoidal choroidal vasculopathy (IPCV) Retina 10 1 1990 1 8
2. R.M. Ahuja, P.E. Stanga, J.R. Vingerling, A.C. Reck, and A.C. Bird Polypoidal choroidal vasculopathy in exudative and haemorrhagic pigment epithelial detachments Br J Ophthalmol 84 5 2000 479 484
3. K. Sho, K. Takahashi, and H. Yamada Polypoidal choroidal vasculopathy: incidence, demographic features, and clinical characteristics Arch Ophthalmol 121 10 2003 1392 1396
4. F. Wen, C. Chen, D. Wu, and H. Li Polypoidal choroidal vasculopathy in elderly Chinese patients Graefes Arch Clin Exp Ophthalmol 242 8 2004 625 629
5. I. Maruko, T. Iida, M. Saito, D. Nagayama, and K. Saito Clinical characteristics of exudative age-related macular degeneration in Japanese patients Am J Ophthalmol 144 1 2007 15 22
6. S.H. Byeon, S.C. Lee, H.S. Oh, S.S. Kim, H.J. Koh, and O.W. Kwon Incidence and clinical patterns of polypoidal choroidal vasculopathy in Korean patients Jpn J Ophthalmol 52 1 2008 57 62
7. Y. Tano Ophthalmic PDT Study Group Guidelines for PDT in Japan Ophthalmology 115 3 2008 585 585.e6
8. W.M. Chan, D.S. Lam, and T.Y. Lai Photodynamic therapy with verteporfin for symptomatic polypoidal choroidal vasculopathy: one-year results of a prospective case series Ophthalmology 111 8 2004 1576 1584
9. A. Otani, M. Sasahara, and Y. Yodoi Indocyanine green angiography: guided photodynamic therapy for polypoidal choroidal vasculopathy Am J Ophthalmol 144 1 2007 7 14
10. C.M. Eandi, M.D. Ober, K.B. Freund, J.S. Slakter, and L.A. Yannuzzi Selective photodynamic therapy for neovascular age-related macular degeneration with polypoidal choroidal neovascularization Retina 27 7 2007 825 831
11. F. Gomi, M. Ohji, and K. Sayanagi One-year outcomes of photodynamic therapy in age-related macular degeneration and polypoidal choroidal vasculopathy in Japanese patients Ophthalmology 115 1 2008 141 146
12. E. Akaza, R. Mori, and M. Yuzawa Long-term results of photodynamic therapy of polypoidal choroidal vasculopathy Retina 28 5 2008 717 722
13. M. Saito, T. Iida, and D. Nagayama Photodynamic therapy with verteporfin for age-related macular degeneration or polypoidal choroidal vasculopathy: comparison of the presence of serous retinal pigment epithelial detachment Br J Ophthalmol 92 12 2008 1642 1647
14. F. Gomi, M. Sawa, and H. Sakaguchi Efficacy of intravitreal bevacizumab for polypoidal choroidal vasculopathy Br J Ophthalmol 92 1 2008 70 73
15. G.T. Kokame, L. Yeung, and J.C. Lai Continuous anti-VEGF treatment with ranibizumab for polypoidal choroidal vasculopathy: 6-month results Br J Ophthalmol 94 3 2009 297 301
16. T. Hikichi, H. Ohtsuka, and M. Higuchi Improvement of angiographic findings of polypoidal choroidal vasculopathy after intravitreal injection of ranibizumab monthly for 3 months Am J Ophthalmol 150 5 2010 674 682
17. I. Maruko, T. Iida, Y. Sugano, M. Saito, and T. Sekiryu Subfoveal retinal and choroidal thickness after verteporfin photodynamic therapy for polypoidal choroidal vasculopathy Am J Ophthalmol 151 4 2011 594 603
18. F. Gomi, M. Sawa, T. Wakabayashi, Y. Sasamoto, M. Suzuki, and M. Tsujikawa Efficacy of intravitreal bevacizumab combined with photodynamic therapy for polypoidal choroidal vasculopathy Am J Ophthalmol 150 1 2010 48 54.e1
19. P. Ruamviboonsuk, M. Tadarati, S. Vanichvaranont, P. Hanutsaha, and N. Pokawattana Photodynamic therapy combined with ranibizumab for polypoidal choroidal vasculopathy: results of a 1-year preliminary study Br J Ophthalmol 94 8 2010 1045 1051
20. T. Sato, S. Kishi, H. Matsumoto, and R. Mukai Combined photodynamic therapy with verteporfin and intravitreal bevacizumab for polypoidal choroidal vasculopathy Am J Ophthalmol 149 6 2010 947 954
21. M. Saito, T. Iida, and M. Kano Combined intravitreal ranibizumab and photodynamic therapy for polypoidal choroidal vasculopathy Retina 32 7 2012 1272 1279
22. R.F. Spaide, H. Koizumi, and M.C. Pozonni Enhanced depth imaging spectral-domain optical coherence tomography Am J Ophthalmol 146 4 2008 496 500
23. Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials - TAP Report 1 Arch Ophthalmol 117 10 1999 1329 1345
24. Verteporfin Roundtable 2000 and 2001 Participants; study group principal investigators Guidelines for using verteporfin (Visudyne) in photodynamic therapy to treat choroidal neovascularization due to age-related macular degeneration and other causes Retina 22 1 2002 6 18
25. T. Wygnanski-Jaffe, H. Desatnik, and A. Alhalel ICG angiography-guided photodynamic therapy for large pigment epithelial detachments in age-related macular degeneration Ophthalmic Surg Lasers Imaging 37 5 2006 358 363
26. Verteporfin Roundtable Participants Guidelines for using verteporfin (Visudyne) in photodynamic therapy for choroidal neovascularization due to age-related macular degeneration and other causes: update Retina 25 2 2005 119 134
27. P.J. Rosenfeld, D.M. Brown, and J.S. Heier Ranibizumab for neovascular age-related macular degeneration N Engl J Med 355 14 2006 1419 1431
28. D.M. Brown, M. Michels, and P.K. Kaiser Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration: Two-year results of the ANCHOR study Ophthalmology 116 1 2009 57 65
29. C.A.T.T. Research Group, D.F. Martin, and M.G. Maguire Ranibizumab and bevacizumab for neovascular age-related macular degeneration N Engl J Med 364 20 2011 1897 1908
30. Japanese Age-Related Macular Degeneration Trial (JAT) Study Group Japanese age-related macular degeneration trial: 1-year results of photodynamic therapy with verteporfin in Japanese patients with subfoveal choroidal neovascularization secondary to age-related macular degeneration Am J Ophthalmol 136 6 2003 1049 1061
31. I. Maruko, T. Iida, Y. Sugano, A. Ojima, and T. Sekiryu Subfoveal choroidal thickness in fellow eyes of patients with central serous chorioretinopathy Retina 31 8 2011 1603 1608
32. S.E. Chung, S.W. Kang, J.H. Lee, and Y.T. Kim Choroidal thickness in polypoidal choroidal vasculopathy and exudative age-related macular degeneration Ophthalmology 118 5 2011 840 845
33. H. Koizumi, T. Yamagishi, T. Yamazaki, R. Kawasaki, and S. Kinoshita Subfoveal choroidal thickness in typical age-related macular degeneration and polypoidal choroidal vasculopathy Graefes Arch Clin Exp Ophthalmol 249 8 2011 1123 1128
34. M. Sasahara, A. Tsujikawa, and K. Musashi Polypoidal choroidal vasculopathy with choroidal vascular hyperpermeability Am J Ophthalmol 142 4 2006 601 607
35. P. Jirarattanasopa, S. Ooto, and I. Nakata Choroidal thickness, vascular hyperpermeability, and complement factor H in age-related macular degeneration and polypoidal choroidal vasculopathy Invest Ophthalmol Vis Sci 53 7 2012 3663 3672